| 摘要 |
<p>C:WRPonbl/DCC/SZP 041289 I.DOC4I 2/2011 Humanized antibodies are provided that specifically bind HLA-DR. The antibodies recognize the epitope recognized by the murine monoclonal antibody L243. Processes for 5 preparing such antibodies, pharmaceutical compositions containing such antibodies, and clinical therapeutic and diagnostic, as well as research-related uses for such antibodies, are provided.</p> |
